<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02837432</url>
  </required_header>
  <id_info>
    <org_study_id>19771</org_study_id>
    <nct_id>NCT02837432</nct_id>
  </id_info>
  <brief_title>The Effect of Cortisol Administration on Neural Correlates of Emotion in Depression</brief_title>
  <official_title>The Effect of Cortisol Administration on Neural Correlates of Emotion in Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is good evidence to suggest that the pathological version of sadness that people with&#xD;
      Major Depression experience could be caused by the failure of the hormone cortisol to&#xD;
      properly inhibit sadness-related brain activity in the subgenual cingulate cortex. This&#xD;
      project investigates if the subgenual cingulate cortex has become insensitive to cortisol in&#xD;
      patients with depression and tests for variants of the cortisol receptor genes that could&#xD;
      predispose individuals to develop cortisol insensitivity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Actual">November 15, 2020</completion_date>
  <primary_completion_date type="Actual">December 13, 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sadness-induced subgenual cingulate activity as measured by functional magnetic resonance imaging.</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">192</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy individuals will receive both the placebo and hydrocortisone interventions in a randomized order</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Depression</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Individuals with depression will receive both the placebo and hydrocortisone interventions in a randomized order</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone acetate</intervention_name>
    <arm_group_label>Depression</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
    <other_name>Cortef</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Depression</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        https://redcap.stanford.edu/surveys/?s=3F7WCENPND&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy Participants must have no Axis 1 mental disorder&#xD;
&#xD;
          -  Participants with depression must meet minimum severity levels (Hamilton &gt;7)&#xD;
&#xD;
          -  All participants must weight less than 280 pounds for the purposes of MRI scanning&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        In order to protect against risk associated with taking Hydrocortisone, all participants&#xD;
        must not have any of the following:&#xD;
&#xD;
          -  Psychotropic medications&#xD;
&#xD;
          -  Recent surgery&#xD;
&#xD;
          -  Endocrine disorders&#xD;
&#xD;
          -  Liver disease&#xD;
&#xD;
          -  Kidney disease&#xD;
&#xD;
          -  Thyroid disorder&#xD;
&#xD;
          -  History of malaria&#xD;
&#xD;
          -  Tuberculosis&#xD;
&#xD;
          -  Osteoporosis&#xD;
&#xD;
          -  Glaucoma/cataracts&#xD;
&#xD;
          -  Chronic expressed infections (herpes --including ocular herpes, HIV, etc.)&#xD;
&#xD;
          -  History of congestive heart failure&#xD;
&#xD;
          -  History of recurring seizures&#xD;
&#xD;
          -  Stomach Ulcers&#xD;
&#xD;
          -  Comorbid psychosis&#xD;
&#xD;
          -  Current use of illicit drugs&#xD;
&#xD;
          -  High Blood pressure&#xD;
&#xD;
        In order to protect against risks associated with MRI scanning participants must not&#xD;
        be/have any of the following:&#xD;
&#xD;
          -  &gt;280 lbs&#xD;
&#xD;
          -  In-dwelling ferrous metals&#xD;
&#xD;
          -  Left Handed&#xD;
&#xD;
          -  Abnormal Hearing&#xD;
&#xD;
          -  Claustrophobic&#xD;
&#xD;
          -  Head injury with loss of consciousness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith Sudheimer, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychiatry and Behavioral Sciences, 401 Quarry Road</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 15, 2016</study_first_submitted>
  <study_first_submitted_qc>July 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2016</study_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Keith Sudheimer</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Depression</keyword>
  <keyword>Cortisol</keyword>
  <keyword>Sadness</keyword>
  <keyword>Genetics</keyword>
  <keyword>Stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone</mesh_term>
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Hydrocortisone hemisuccinate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

